Adenovirus 5 Vectors Expressing SARS-CoV-2 Proteins

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• The SARS-CoV-2 coronavirus causes the ongoing COVID-19 pandemic.
• Understanding SARS-CoV-2's molecular mechanisms is crucial for combating the pandemic.
• New variants necessitate continuous research and development of effective countermeasures.

Purpose of the Study:

• To create novel adenovirus 5-based viral vectors for expressing key SARS-CoV-2 proteins.
• To provide researchers with essential tools for studying SARS-CoV-2.
• To facilitate research into virus-host interactions and immune evasion.

Main Methods:

• Adenovirus 5 vectors engineered to express SARS-CoV-2 proteins (S, N, E, NSP7, NSP8, NSP12) and protein domains (RBD, RBD-N).
• Expression verified using Western blotting and quantitative reverse transcriptase PCR (qRT-PCR).
• Subcellular localization and cellular target binding of viral proteins assessed.

Main Results:

• Successful expression of SARS-CoV-2 proteins and protein domains in various cell lines.
• Confirmed subcellular localization and identified binding interactions with cellular targets.
• Adenovirus vectors demonstrated flexibility for use in cell and animal models.

Conclusions:

• The developed viral vectors are effective tools for SARS-CoV-2 research.
• These reagents will advance the understanding of SARS-CoV-2 molecular biology and pathogenesis.
• Availability of these tools is vital for pandemic control and future outbreak preparedness.